Compare Twist Bioscience Corp (TWST) vs Financial Select Sector SPDR Fund (XLF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Twist Bioscience Corp vs Financial Select Sector SPDR Fund — how do they compare? Twist Bioscience Corp trades at $88.31 (market cap $5.45B), while Financial Select Sector SPDR Fund trades at $56.11. The key difference: Financial Select Sector SPDR Fund is trading nearer its 52-week high, Twist Bioscience Corp nearer its low. Which is the better fit depends on your goals.
| TWST | XLF | |
|---|---|---|
Market Cap | $5.45B | — |
Sector | Health | — |
52-Week High | $102.88 | $56.75 |
52-Week Low | $24.16 | $47.80 |
Enterprise Value | $5.37B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TWST trades at $95.86, up 2.14% today, with a bullish technical signal and strong institutional interest. Revenue growth is robust, rising from $204M in 2022 to $377M in 2025, though the company remains unprofitable with a net income margin of -19.85%. Recent news highlights AI-driven collaborations and earnings beats, but cash flow trends show persistent operational losses.
The outlook is mixed; analyst consensus is bullish with a $91.63 price target, but profitability challenges and negative cash flows pose significant risks. Investment opportunity lies in continued revenue expansion and AI partnerships, while execution risks and high valuations require caution.
XLF trades at $56.04, down 0.39% today, with technical indicators showing a bullish trend supported by moving averages while oscillators remain neutral. The ETF holds 76 financial companies and benefits from strong bank earnings, with recent news highlighting its low expense ratio of 0.08% and exposure to diversified financials. Geopolitical tensions and potential Federal Reserve rate hikes are key market drivers.
Outlook remains positive due to robust sector earnings and potential rate hike benefits, though risks include geopolitical volatility and high investor expectations. Wall Street sentiment is cautiously optimistic, with technical support near $56.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →About Financial Select Sector SPDR Fund
The fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: diversified financial services; insurance; banks; capital markets; mortgage real estate investment trusts; consumer finance; thrifts; and mortgage finance. The fund is non-diversified.
Read more on XLF →
